Key Insights

Highlights

Success Rate

44% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 77/100

Termination Rate

33.3%

5 terminated out of 15 trials

Success Rate

44.4%

-42.1% vs benchmark

Late-Stage Pipeline

13%

2 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed with results

Key Signals

2 with results44% success

Data Visualizations

Phase Distribution

8Total
Not Applicable (6)
P 3 (1)
P 4 (1)

Trial Status

Terminated5
Completed4
Recruiting2
Not Yet Recruiting2
Unknown2

Trial Success Rate

44.4%

Benchmark: 86.5%

Based on 4 completed trials

Clinical Trials (15)

Research Network

Activity Timeline